Cedric Mpoy
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 6
- Radiopharmaceutical Chemistry and Applications 5
-
- Cell Adhesion Molecules Research 2
- Co-authors
- Buck E. RogersJulie K. SchwarzJohn BaerBrett L. KnolhoffDavid G. DeNardoChong ZuoGraham D. HoggRyan C. Fields
- Journals
- Journal of Nuclear Medicine (3 papers)Pharmaceuticals (2 papers)Cancer Cell (2 papers)GeroScience (1 paper)Cancer Discovery (1 paper)
- Partner nations
- United StatesAustraliaBrazil
In The Last Decade
Cedric Mpoy
24 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 85
- Oncology 529
- Immunology 372
- Parasitology 84
- Radiology, Nuclear Medicine and Imaging 199
- Cancer Research 105
Countries citing papers authored by Cedric Mpoy
This map shows the geographic impact of Cedric Mpoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cedric Mpoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cedric Mpoy more than expected).
Fields of papers citing papers by Cedric Mpoy
This network shows the impact of papers produced by Cedric Mpoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cedric Mpoy. The network helps show where Cedric Mpoy may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Cedric Mpoy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 5 | |
| 2 | 2023 | 6 | |
| 3 | 2023 | 15 | |
| 4 | 2023 | 53 | |
| 5 | 2022 | 66 | |
| 6 | 2022 | 16 | |
| 7 | 2022 | 24 | |
| 8 | 2021 | 93 | |
| 9 | 2021 | 85 | |
| 10 | 2021 | 21 | |
| 11 | A Cu-64/Cu-67 Bombesin ligand as a theranostic for cancer | 2021 | 2 |
| 12 | 2020 | 72 | |
| 13 | 2020 | 15 | |
| 14 | 2020 | 295 | |
| 15 | 2019 | 14 | |
| 16 | 2018 | 33 | |
| 17 | 2018 | 6 | |
| 18 | 2018 | 66 | |
| 19 | 2018 | 27 | |
| 20 | 2012 | 108 |
About Cedric Mpoy
Cedric Mpoy is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Oncology, Immunology and Virology, having authored 25 papers that have together received 1.0k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (6 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Prostate Cancer Treatment and Research (3 papers), PARP inhibition in cancer therapy (3 papers), Glycosylation and Glycoproteins Research (2 papers), DNA Repair Mechanisms (2 papers) and Cell Adhesion Molecules Research (2 papers). The work is most often cited by research in Oncology (529 citations), Immunology (372 citations), Parasitology (84 citations), Radiology, Nuclear Medicine and Imaging (199 citations) and Cancer Research (105 citations). Cedric Mpoy has collaborated with scholars based in United States, Australia and Brazil. Frequent co-authors include Buck E. Rogers, Julie K. Schwarz, John Baer, Brett L. Knolhoff, David G. DeNardo, Chong Zuo, Graham D. Hogg, Ryan C. Fields, Samarth Hegde and Kenneth M. Murphy. Their work appears in journals such as Journal of Nuclear Medicine, Pharmaceuticals, Cancer Cell, GeroScience and Cancer Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.